New cases come from SEER 12. Deaths come from U.S. Mortality. All Races, Males. Rates are Age-Adjusted. Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software. The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Age-Adjusted Rates of New Cases/Deaths Per 100,000 & 5-Year Relative Survival Percentages
Year
Rate of New Cases — SEER 8
Rate of New Cases — SEER 12
Death Rate — U.S.
5-Year Relative Survival — SEER 8
Observed
Modeled Trend
Observed
Modeled Trend
Observed
Modeled Trend
Observed
Modeled Trend
1975
95.39
96.26
-
-
30.94
31.41
67.68%
68.42%
1976
97.31
97.69
-
-
31.74
31.70
70.07%
69.27%
1977
100.12
99.13
-
-
31.85
32.01
70.69%
70.09%
1978
98.93
100.60
-
-
32.69
32.31
71.09%
70.90%
1979
103.13
102.09
-
-
32.86
32.62
72.06%
71.68%
1980
105.12
103.61
-
-
33.09
32.93
71.87%
72.46%
1981
106.14
105.14
-
-
33.28
33.24
73.31%
73.21%
1982
105.39
106.70
-
-
33.49
33.56
73.57%
73.95%
1983
108.27
108.28
-
-
34.06
33.88
74.33%
74.67%
1984
108.55
109.88
-
-
34.17
34.20
74.44%
75.38%
1985
114.24
111.51
-
-
34.05
34.52
75.67%
76.07%
1986
117.29
113.17
-
-
35.08
34.85
77.95%
76.74%
1987
131.94
126.22
-
-
35.33
35.18
81.25%
81.23%
1988
136.53
140.78
-
-
36.15
36.39
84.33%
84.93%
1989
143.15
157.01
-
-
37.43
37.63
85.49%
87.96%
1990
167.08
175.12
-
-
38.90
38.92
89.71%
90.41%
1991
205.86
195.32
-
-
39.61
39.30
93.09%
92.39%
1992
224.93
217.85
225.11
222.35
39.74
39.69
96.72%
93.97%
1993
196.09
198.58
197.60
198.62
39.88
40.07
95.52%
95.23%
1994
172.04
181.01
171.45
177.42
39.04
38.65
94.99%
96.24%
1995
162.90
165.00
161.81
158.49
37.78
37.28
95.72%
97.03%
1996
163.05
165.35
161.99
161.43
36.48
35.96
96.81%
97.66%
1997
166.53
165.70
166.81
164.43
34.57
34.68
97.66%
98.16%
1998
161.45
166.06
162.97
167.49
32.99
33.45
98.20%
98.55%
1999
174.63
166.41
173.84
170.61
31.93
32.27
99.19%
98.86%
2000
174.45
166.76
172.52
173.78
30.81
31.12
99.12%
99.10%
2001
177.18
167.12
174.14
171.08
29.94
30.02
100.00%
99.30%
2002
173.62
167.47
171.43
168.42
29.16
28.96
99.75%
99.45%
2003
163.90
167.83
160.95
165.81
27.60
27.93
99.35%
99.56%
2004
160.08
168.19
161.44
163.23
26.61
26.94
99.83%
99.66%
2005
154.53
168.55
152.35
160.69
25.79
25.98
99.56%
99.73%
2006
169.66
168.90
162.19
158.20
24.64
25.06
99.94%
99.79%
2007
170.89
169.26
164.36
155.74
24.63
24.17
99.90%
99.83%
2008
154.43
157.93
150.68
153.32
23.39
23.32
99.23%
99.75%
2009
151.40
147.36
147.48
150.94
22.50
22.49
99.34%
99.62%
2010
142.69
137.50
140.08
138.64
22.18
21.69
99.56%
99.43%
2011
135.78
128.29
133.52
127.35
21.21
20.92
99.25%
99.15%
2012
112.29
119.70
110.18
116.97
20.04
20.18
98.48%
98.72%
2013
108.86
111.69
105.98
107.44
19.81
20.07
98.18%
98.07%
2014
100.16
104.21
97.48
98.69
19.71
19.96
97.57%
97.11%
2015
107.32
107.30
101.41
101.61
19.60
19.84
97.25%
97.48%
2016
110.56
110.48
104.63
104.61
20.12
19.73
98.14%
97.81%
2017
116.71
113.75
110.50
107.71
19.63
19.62
98.03%
98.09%
2018
118.91
117.12
112.02
110.90
19.75
19.51
-
98.34%
2019
123.23
120.59
116.16
114.18
19.36
19.40
-
98.56%
2020
109.08
124.16
103.10
117.56
19.59
19.30
-
98.75%
2021
129.47
127.84
122.88
121.04
19.15
19.19
-
98.91%
2022
126.75
131.63
120.36
124.62
19.07
19.08
-
99.05%
2023
-
-
-
-
18.71
18.97
-
99.18%
Rate of New Cases and Deaths per 100,000: The rate of new cases of prostate cancer was 120.2 per 100,000 men per year. The death rate was 19.2 per 100,000 men per year. These rates are age-adjusted and based on 2018–2022 cases and 2019–2023 deaths.
Lifetime Risk of Developing Cancer: Approximately 12.9 percent of men will be diagnosed with prostate cancer at some point during their lifetime, based on 2018–2021 data, excluding 2020 due to COVID.
Prevalence of This Cancer: In 2022, there were an estimated 3,518,978 men living with prostate cancer in the United States.
Did You Know? Video Series
Did You Know? Video Series
How Many People Survive 5 Years Or More after Being Diagnosed with Prostate Cancer?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
5-Year Relative Survival
97.9%
Based on data from SEER 21 (Excluding IL) 2015–2021. Gray figures represent those who have died from prostate cancer. Green figures represent those who have survived 5 years or more.
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. For prostate cancer, 69.1% are diagnosed at the local stage. The 5-year relative survival for localized prostate cancer is 100.0%.
Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Prostate Cancer
Stage
Percent of Cases
5-Year Relative Survival
Localized Confined to Primary Site
69%
100.0%
Regional Spread to Regional Lymph Nodes
14%
100.0%
Distant Cancer Has Metastasized
8%
37.9%
Unknown Unstaged
9%
93.7%
Percent of Cases by Stage
Localized (69%) Confined to Primary Site
Regional (14%) Spread to Regional Lymph Nodes
Distant (8%) Cancer Has Metastasized
Unknown (9%) Unstaged
5-Year Relative Survival
SEER 21 (Excluding IL) 2015–2021, All Races, Males by SEER Combined Summary Stage
Compared to other cancers, prostate cancer is fairly common.
Rank
Common Types of Cancer
Estimated New Cases 2025
Estimated Deaths 2025
1.
Breast Cancer (Female)
316,950
42,170
2.
Prostate Cancer
313,780
35,770
3.
Lung and Bronchus Cancer
226,650
124,730
4.
Colorectal Cancer
154,270
52,900
5.
Melanoma of the Skin
104,960
8,430
6.
Bladder Cancer
84,870
17,420
7.
Kidney and Renal Pelvis Cancer
80,980
14,510
8.
Non-Hodgkin Lymphoma
80,350
19,390
9.
Uterine Cancer
69,120
13,860
10.
Pancreatic Cancer
67,440
51,980
Prostate cancer represents 15.4% of all new cancer cases in the U.S.
15.4%
In 2025, it is estimated that there will be 313,780 new cases of prostate cancer and an estimated 35,770 people will die of this disease.
Who Gets This Cancer?
Prostate cancer occurs only in men, and it is more common in older men than younger men. It is more likely to occur in men with a family history of prostate cancer and non-Hispanic Black men. The rate of new cases of prostate cancer was 120.2 per 100,000 men per year based on 2018–2022 cases, age-adjusted.
Rate of New Cases per 100,000 Persons by Race/Ethnicity: Prostate Cancer
Males
All Races
120.2
Hispanic
90.2
Non-Hispanic American Indian/Alaska Native
82.2
Non-Hispanic Asian/Pacific Islander
64.5
Non-Hispanic Black
194.8
Non-Hispanic White
118.9
Females
All Races
Sex-specific cancer type
Hispanic
Non-Hispanic American Indian/Alaska Native
Non-Hispanic Asian/Pacific Islander
Non-Hispanic Black
Non-Hispanic White
All Races
Hispanic
Non-Hispanic American Indian/ Alaska Native
Non-Hispanic Asian / Pacific Islander
Non-Hispanic Black
Non-Hispanic White
SEER 21 2018–2022, Age-Adjusted
Percent of New Cases by Age Group: Prostate Cancer
Age Range
Percent of New Cases
<20
0.0%
20–34
0.0%
35–44
0.3%
45–54
6.0%
55–64
29.4%
65–74
42.9%
75–84
17.6%
>84
3.8%
Prostate cancer is most frequently diagnosed among men aged 65–74.
Median Age At Diagnosis
68
SEER 21 2018–2022, All Races, Males
Who Dies From This Cancer?
Because we have screening for prostate cancer, most of the time it is caught before it spreads to other parts of the body. Men who have prostate cancer that is characterized as localized or regional are not as likely to die as men whose cancer is distant. In general prostate cancer has excellent survival rates, but death rates are higher in non-Hispanic Black men, men who have advanced stage cancer, and men who are between the ages of 75 and 84. Prostate cancer is the fifth leading cause of cancer death in the United States. The death rate was 19.2 per 100,000 men per year based on 2019–2023, age-adjusted.
Death Rate per 100,000 Persons by Race/Ethnicity: Prostate Cancer
Males
All Races
19.2
Hispanic
15.4
Non-Hispanic American Indian/Alaska Native
18.9
Non-Hispanic Asian/Pacific Islander
8.8
Non-Hispanic Black
36.9
Non-Hispanic White
18.4
Females
All Races
Sex-specific cancer type
Hispanic
Non-Hispanic American Indian/Alaska Native
Non-Hispanic Asian/Pacific Islander
Non-Hispanic Black
Non-Hispanic White
All Races
Hispanic
Non-Hispanic American Indian/ Alaska Native
Non-Hispanic Asian / Pacific Islander
Non-Hispanic Black
Non-Hispanic White
U.S. 2019–2023, Age-Adjusted
Percent of Deaths by Age Group: Prostate Cancer
Age Range
Percent of Deaths
<20
0.0%
20–34
0.0%
35–44
0.1%
45–54
1.1%
55–64
8.6%
65–74
24.8%
75–84
34.1%
>84
31.3%
The percent of prostate cancer deaths is highest among men aged 75–84.
Median Age At Death
79
U.S. 2019–2023, All Races, Males
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new prostate cancer cases have been rising on average 1.8% each year over 2013–2022. Age-adjusted death rates have been falling on average 0.6% each year over 2014–2023. 5-year relative survival trends are shown below.
New Cases, Deaths and 5-Year Relative Survival
Rate of New Cases
Death Rate
New cases come from SEER 8. Deaths come from U.S. Mortality. All Races, Males. Rates are Age-Adjusted. Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software. The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
5-Year Relative Survival
SEER 8 5-Year Relative Survival Percent from 1975–2017, All Races, Males. Modeled trend lines were calculated from the underlying rates using the Joinpoint Survival Model Software.
With SEER*Explorer, you can...
Create custom graphs and tables
Download data and images
Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Figure: Anatomy diagram shows the prostate, urethra, penis, testicle, bladder, lymph nodes, seminal vesicle, and rectum are labeled. An inset provides a close-up view of the prostate, urethra, bladder, seminal vesicles, and rectum.
Figure: Prostate and Nearby Organs
Figure: Anatomy diagram shows the prostate, urethra, penis, testicle, bladder, lymph nodes, seminal vesicle, and rectum are labeled. An inset provides a close-up view of the prostate, urethra, bladder, seminal vesicles, and rectum.
This cancer forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). The prostate surrounds the urethra, the tube through which urine flows. A healthy prostate is about the size of a walnut. If the prostate grows too large, it squeezes the urethra. This may slow or stop the normal flow of urine. Prostate cancer usually occurs in older men.
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
Suggested Citation
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2025 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.
An official website of the United States government
Localized (69%)
Regional (14%)
Distant (8%)
Unknown (9%)
